Bristol-Myers Squibb Market Cap 2006-2018 | BMY

Bristol-Myers Squibb market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Bristol-Myers Squibb market cap as of April 22, 2019 is $73.92B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $73.920B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $369.784B 16.77
Pfizer (PFE) United States $232.043B 12.99
Merck (MRK) United States $198.062B 16.93
Novartis AG (NVS) Switzerland $174.174B 14.81
Eli Lilly (LLY) United States $119.606B 20.77
Novo Nordisk (NVO) Denmark $117.534B 19.01
AbbVie (ABBV) United States $115.278B 9.88
Sanofi (SNY) France $103.709B 12.80
GlaxoSmithKline (GSK) United Kingdom $98.430B 12.93
AstraZeneca (AZN) United Kingdom $98.150B 11.20